112 related articles for article (PubMed ID: 21320136)
1. Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia.
Hassall E; Owen D; Kerr W; Sturby T; Richardson P; El-Serag H
Aliment Pharmacol Ther; 2011 Apr; 33(7):829-36. PubMed ID: 21320136
[TBL] [Abstract][Full Text] [Related]
2. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
3. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety concerns with proton pump inhibitors.
Ali T; Roberts DN; Tierney WM
Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
[TBL] [Abstract][Full Text] [Related]
5. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
7. Review article: the long-term use of proton-pump inhibitors.
Raghunath AS; O'Morain C; McLoughlin RC
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():55-63. PubMed ID: 16042660
[TBL] [Abstract][Full Text] [Related]
8. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
Jianu CS; Lange OJ; Viset T; Qvigstad G; Martinsen TC; Fougner R; Kleveland PM; Fossmark R; Hauso Ø; Waldum HL
Scand J Gastroenterol; 2012 Jan; 47(1):64-7. PubMed ID: 22087794
[TBL] [Abstract][Full Text] [Related]
9. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?
Eslami L; Nasseri-Moghaddam S
Arch Iran Med; 2013 Aug; 16(8):449-58. PubMed ID: 23906249
[TBL] [Abstract][Full Text] [Related]
10. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
11. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].
Mouterde O; Bellaïche M; Dumant C; Mallet E
Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868
[No Abstract] [Full Text] [Related]
12. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
13. Considerations for long-term use of proton-pump inhibitors.
Garnett WR
Am J Health Syst Pharm; 1998 Nov; 55(21):2268-79. PubMed ID: 9825878
[TBL] [Abstract][Full Text] [Related]
14. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
Lee JH; Kim MJ; Lee JS; Choe YH
Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
[TBL] [Abstract][Full Text] [Related]
15. [Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results].
Cadiot G; Vissuzaine C; Pospai D; Ruszniewski P; Potet F; Mignon M
Gastroenterol Clin Biol; 1995 Oct; 19(10):811-7. PubMed ID: 8566561
[TBL] [Abstract][Full Text] [Related]
16. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh VQ; Shi C; Ma C
Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
[TBL] [Abstract][Full Text] [Related]
17. Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.
Rais R; Trikalinos NA; Liu J; Chatterjee D
Arch Pathol Lab Med; 2022 Mar; 146(3):366-371. PubMed ID: 34283890
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
Kuipers EJ; Klinkenberg-Knol EC; Meuwissen SG
Yale J Biol Med; 1999; 72(2-3):211-8. PubMed ID: 10780583
[TBL] [Abstract][Full Text] [Related]
19. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
[TBL] [Abstract][Full Text] [Related]
20. PPIs, H. pylori, and atrophic gastritis: putting the issue to rest?
DiBaise JK
Am J Gastroenterol; 1999 Dec; 94(12):3403. PubMed ID: 10606289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
